Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer.
about
Chronopharmacology: new insights and therapeutic implicationsThe circadian clock in cancer development and therapySystems ChronotherapeuticsThoracic surface temperature rhythms as circadian biomarkers for cancer chronotherapyGinseng Purified Dry Extract, BST204, Improved Cancer Chemotherapy-Related Fatigue and Toxicity in Mice.Circadian actigraphic rest-activity rhythms following surgery for endometrial cancer: A prospective, longitudinal study.Relevance of internal time and circadian robustness for cancer patients.Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancerA murine model of peripheral irradiation-induced fatigue.Implications of Circadian Rhythm Regulation by microRNAs in Colorectal CancerRecommendations for high-priority research on cancer-related fatigue in children and adults.Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project.The circadian timing system in clinical oncology.Proteomics and circadian rhythms: it's all about signaling!Precise periodic components estimation for chronobiological signals through Bayesian Inference with sparsity enforcing prior.Residential road traffic noise exposure and colorectal cancer survival - A Danish cohort study.Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer.Correlation between rest-activity rhythm and survival in cancer patients experiencing pain.Relationship between subjective and actigraphy-measured sleep in 237 patients with metastatic colorectal cancer.Circadian rhythms accelerate wound healing in female Siberian hamsters.The effect of melatonin on sleep and quality of life in patients with advanced breast cancer.Colorectal liver metastases with a disrupted circadian rhythm phase shift the peripheral clock in liver and kidney.Critical cholangiocarcinogenesis control by cryptochrome clock genes.Circadian clock and oral cancer.The circadian rest-activity rhythm, a potential safety pharmacology endpoint of cancer chemotherapy.Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival.The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.Altered Circadian Rhythms and Breast Cancer: From the Human to the Molecular LevelCircadian rest-activity rhythm as an objective biomarker of patient-reported outcomes in patients with advanced cancer
P2860
Q27022411-1406CE7B-0265-454D-9EB5-9D4B9609240DQ28390451-98FC2ACF-362E-42CC-B0F1-B83AB7D1A6B4Q33573675-57FB8AE0-EE37-4BF2-8D91-B2EFBFA5278CQ34457499-4B79CFB3-A338-43E4-ADF8-3A2AD64F81E8Q35511894-A086B149-8E44-4F31-B151-6369DC088A17Q35673841-43E89526-D3DE-4AB0-9B1A-79B5813797D3Q35996492-D3921C25-AA4A-4EA4-8E39-ADA223C87D89Q36671163-1D4CBA37-48E2-45C6-A165-AC343D2ADB54Q36858665-D001817F-C66C-4030-B310-4AF2C48E17A1Q37341203-1C418445-6A4A-46BE-A16A-F78F24E4305AQ37463262-7EB19B2B-DCE6-498C-BF6C-78529B6ED728Q37490938-88C7BC07-3408-4AB4-86BB-CC108146F091Q38219193-497DCA45-83D1-475B-BA67-51E4E520C11DQ38237941-CAD8B535-2E62-4250-BCE7-52A3CB666171Q40033720-E7CA438E-BBF1-48DC-A1A1-11504562B262Q45061885-495E888E-C72F-41C3-97D1-DAE478508836Q45850052-967695E5-7196-4233-BCD9-D43DC2F94F7EQ45918443-82970435-254E-415A-85DD-7E301A203F5FQ47715580-36F42FD3-3FD7-4DFB-9965-9B51FCDE5108Q47912649-3251C1EF-BF5D-48FD-8005-901DBC13FB61Q47948007-A429A344-A7DE-4A33-BD4F-503FB387A371Q48092664-70338E10-3CFF-48F0-B866-094C8DA4441DQ48209599-5AC4E221-4003-42E2-971E-E34ABD3DF15DQ50045797-D66DB38B-A047-4823-BF20-5A40EEEA8E6AQ52647652-1ACB7A75-25EC-4A94-BA7A-BD03693955D2Q52651068-17B457BA-AF5E-49AE-A810-2CBDF7A09223Q52727400-957204DA-19E9-4865-80ED-7DE17AEEA9ABQ54157077-A1E74B54-4B59-4F40-A85A-28EFF0EB7E78Q58796654-82540A9C-F5B3-4144-8CDB-E9FF8EBDCDA6
P2860
Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prediction of overall survival ...... metastatic colorectal cancer.
@en
Prediction of overall survival ...... metastatic colorectal cancer.
@nl
type
label
Prediction of overall survival ...... metastatic colorectal cancer.
@en
Prediction of overall survival ...... metastatic colorectal cancer.
@nl
prefLabel
Prediction of overall survival ...... metastatic colorectal cancer.
@en
Prediction of overall survival ...... metastatic colorectal cancer.
@nl
P2093
P2860
P50
P921
P356
P1476
Prediction of overall survival ...... r metastatic colorectal cancer
@en
P2093
Carlo Garufi
Christian Focan
Francis A Lévi
Jim Waterhouse
Marie-Christine Mormont
Pasquale F Innominato
Stefano Iacobelli
Sylvie Giacchetti
P2860
P304
P356
10.1002/IJC.27574
P577
2012-07-03T00:00:00Z